REMINDER: Our focusIR Investor Webinar takes place TONIGHT with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProvexis Share News (PXS)

Share Price Information for Provexis (PXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.60
Bid: 0.55
Ask: 0.65
Change: 0.00 (0.00%)
Spread: 0.10 (18.182%)
Open: 0.60
High: 0.00
Low: 0.00
Prev. Close: 0.60
PXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS: Ebiquity swings to profit; SDX Energy swings to loss

Fri, 29th Sep 2023 11:51

(Alliance News) - The following is a round-up of earning and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

----------

Ebiquity PLC - London-based media and marketing consultancy - Swings to pretax profit in the first half of 2023 of GBP1.4 million, from a loss of GBP1.4 million a year prior. Revenue climbs 11% to GBP40.6 million from GBP36.7 million. Declares no dividend, unchanged. On the company's outlook, Chief Executive Officer Nick Waters says: "While we are seeing some major customers cutting budgets as a result of prevailing market conditions and trends, Ebiquity continues to trade broadly in line with expectations. Looking further ahead, as the market leader we remain well positioned to help our clients and see further opportunities for revenue growth and margin enhancement."

----------

Hydrogen Utopia International PLC - London-based operator of facilities that turn non-recyclable mixed waste plastic into hydrogen and other carbon-free fuels, new materials, or distributed renewable heat - In the first half of 2023, pretax loss widens to GBP766,836 from GBP583,874 a year prior. Posts no revenue in either half-year. Says outlook remains "very" positive, cites high degree of confidence in executing strategy.

----------

Provexis PLC - Reading, England-based producer of heart-health functional food ingredient Fruitflow - In the financial year to March 31, pretax loss widens to GBP419,916 from GBP299,132 a year prior. Revenue falls to GBP389,916 from GBP426,168. Cost of goods sold increases to GBP95,497 from GBP46,119. Looking ahead, Chair Dawson Buck and CEO Ian Ford say board is "strongly positive about the outlook for Fruitflow and the Provexis business for the coming year and beyond."

----------

RegTech Open Project PLC - technology business focused on automation and optimisation of regulatory compliance operations - Announces results for period from March 10 to June 30. Reports GBP50,000 worth of assets as at June 30. Notes 50% annual growth on invoiced basis to GBP588,000 in the first half of 2023 from GBP391,000 a year prior. Reports no profit or loss, revenue, or costs. Company listed on the main market of the London Stock exchange on August 25. Confirms that Paul McFadden will be chief financial officer from December 5. Further, enters into side letter agreement cast as a deed, with RegTech Open Project SpA, ultimately owned by RegTech Open Project PLC founder Alessandro Zamboni. Notes that since completion of direct listing, a total of GBP2.5 million funds have been drawn under English law.

----------

SDX Energy PLC - London-based energy company, with portfolio of exploration, development and production assets in Egypt and Morocco - Swings to pretax loss in the six months to June 30, of USD397,000, from a profit of USD1.9 million a year prior. Revenue net of royalties falls 32% to USD15.3 million from USD22.3 million. Direct operating expense increases 17% to USD5.1 million from USD4.4 million. Looking ahead, cites planned workover of Egypt-based Rabul Deep-1 well, to convert it to a water-injector for the Rabul field.

----------

TechFinancials Inc - purely investment entity since 2022 after closing operating entities in Israel - Pretax loss in the first half of 2023 narrows to USD73,000 from USD163,000 a year prior. Posts no revenue in either half-year. Looking ahead, Chair Eitan Yanuv says: "We will continue to look for opportunities to materialize our assets or join forces with other companies in order to be able move forward."

----------

Verici Dx PLC - Cardiff, Wales-based developer of clinical diagnostics for organ transplants - Pretax loss in the first half of 2023 narrows to USD5.3 million from USD5.5 million prior. Reports USD19,000 revenue compared to none a year ago. Looking ahead, Verici is focused on speeding up the commercial roll-out of Tutivia, Chief Executive Sara Barrington says. Tutivia is a single test that uses RNA signature technology to assist in improving a patient's personalised post-kidney transplant care.

----------

By Tom Budszus, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
5 Aug 2012 14:10

Sunday share tips: GKN, Provexis, BP

First-half numbers from specialist engineer GKN beat market expectations, with pre-tax profits leaping 43 per cent. Nigel Stein, chief executive, also gave some upbeat interviews, indicating that, while many of GKN's customers were cautious about the rest of 2012, "no one is pressing alarm buttons"

Read more
31 Jul 2012 11:51

Small caps: IndigoVision, Silence Therapeutics, Air Partner...

Air Partner, a provider of air charter services, has said underlying profit before tax for the year is expected to meet its forecasts. The firm's cost reduction programme is also now nearly complete and will realise 'significant cost savings' in the next financial year, with a one off restructuring

Read more
14 Feb 2012 10:12

Small caps round-up: Provexis, CareTech, Nanoco ...

Sports nutrition specialist Provexis said an industrial scale production of Fruitflow powder, was successfully completed in 2012. Fruitflow is Provexis's tomato extract which inhibits platelet aggregating and therefore reduces the chance of heart disease. Provexis has identified a potential applic

Read more
15 Dec 2011 15:01

Sector movers: Old Mutual boosts life insurers after Nordic sale

Life insurance stocks were on the rise on Thursday afternoon, helped by FTSE 100 savings, investment and insurance group Old Mutual. Shares in Old Mutual roared higher on Thursday after announcing that it is to sell its Nordic business Skandia AB for £2.1bn in an effort to "reduce complexity" and p

Read more
1 Dec 2011 12:40

First half losses grow at Provexis

Medical food and dietary supplement developer Provexis disappointed investors with widened losses for the six months ended 30 September. The share price fell 23.08% to 1.75p by 13:05. The losses, which grew from £1m to £1.5m, came despite revenues doubling from £0.7m to £1.5m after costs rose signi

Read more
17 Jun 2011 09:20

Provexis hurt by R&D costs, acquisition fails to inspire

Medical food and dietary supplement developer Provexis reported a wider pre-tax loss, hurt by increased research and development expenses, while its plans to acquire a sports nutrition products manufacturer failed to inspire investors. For the year ended March 31, Provexis posted a loss before tax

Read more
16 Dec 2010 07:49

Rising R&D costs hurt Provexis

Medical food and dietary supplement developer Provexis said pre-tax losses almost doubled as it increased research and development spending. Investment in R&D increased to £612,171 in the period, up from £289,125 in the same period last year, as the group broadens its product pipeline. The group

Read more
9 Sep 2010 16:23

Provexis to exhibit Fruitflow later this year

The board of functional and medical food company Provexis has set itself the task in the coming year of maximising the commercial opportunity for Fruitflow, its patented tomato extract which aims to improve heart health. The marketing strategy for Fruitflow is now being finalised and the technology

Read more
26 Jul 2010 16:55

Provexis widens Fruitflow approvals

Functional foods developer Provexis has gained approval from the European Food Safety Authority (EFSA) to use its Fruitflow technology in dietary supplements. Fruitflow was already allowed to be used in drinks by the EFSA. Provexis can also use the claim that Fruitflow "helps maintain normal plate

Read more
26 Jul 2010 07:33

Provexis: Fruitflow Gets Further European Food Safety Approval

LONDON (Dow Jones)--Provexis PLC (PXS.LN), a company which focuses on the discovery, development and licensing of scientifically-proven functional food, medical food and dietary supplement technologies, Monday announces a widening of the European Food Safety Authority (EFSA) opinion on the Company's

Read more
22 Jun 2010 07:33

Provexis Raises GBP88,869 In Draw Down Of Funds, Equity Issue

LONDON (Dow Jones)--Provexis PLC (PXS.LN), which focuses on the discovery, development and licensing of scientifically-proven functional food, medical food and dietary supplement technologies, said Tuesday it has raised net proceeds of GBP88,869 by drawing down on its Equity Financing Facility with

Read more
31 Mar 2010 17:07

London close: Up and down day for London

The movements of the blue-chip index looked like they were being directed by the grand old Duke of York on Wednesday, with the market finishing neither up nor down. British Sky Broadcasting (BSkyB) was predictably outraged at the decision by telecoms regulator Ofcom to order it to make its two top

Read more
31 Mar 2010 16:08

Small caps round-up: Provexis, Renew, Source BioSciences...........

Functional foods developer Provexis expects to have net cash of £7m at the end of March 2010. It has also entered into a three-year, £25m equity financing facility provided by Evolution Securities through its subsidiary Darwin Strategic. This could be used to help finance acquisitions. Renew Holdi

Read more
9 Mar 2010 08:45

Provexis surges on test results

Shares in medical food and dietary supplement developer Provexis shot up on Tuesday after it published the results of a trial of its Fruitflow product, which is designed to reduce the risk of heart attack, stroke and venous thrombosis. Fruitflow, a tomato extract which counters unwanted clot forma

Read more
17 Dec 2009 12:03

Small cap round-up: ILX, Ideal Shopping, Provexis...

E-learning company ILX has won three contracts that are expected to produce revenues of more than £0.27m over the life of the contracts. The first contract is to provide project management training to a major government department over a period of three years. The other two contracts are for overse

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.